Loss of histone H4K20 trimethylation has been documented as a marker of poor prognosis in patients with breast carcinoma and is linked with the invasiveness of breast carcinoma cells in a HER2‐independent manner 51. The gene discussed is ERBB2; the disease is breast carcinoma.